Catalyst Wire Dossier Catalyst Wire Dossier

Lotilaner Ophthalmic Gel

lotilaner · Tarsus Pharmaceuticals, Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Lotilaner Ophthalmic Gel, covering 2026-03-02 to 2026-03-02. Get the full timeline:

Most recent: Clinical Trial Update: Study of Lotilaner Ophthalmic Gel in Patients With Ocular Rosacea (KORE) [Phase 2]

See pricing